MED28 regulates MEK1-dependent cellular migration in human breast cancer cells

Chun-Yin Huang1, Yu-Hsuan Chou, Nien-Tsu Hsieh

  • 1Department of Nutrition, China Medical University, Taichung, Taiwan, ROC.

Insights

MED28 protein promotes human breast cancer cell migration and invasion by upregulating MEK1 and MMP2. Suppressing MED28 inhibits these processes, highlighting MED28 as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • MED28 is a mammalian Mediator subunit implicated in various cellular functions.
  • MED28 is overexpressed in several cancers, including breast cancer.
  • MED28 has been shown to potentiate epidermal growth factor (EGF)-induced migration.

Purpose of the Study:

  • To investigate the role of MED28 in cellular migration and invasion in human breast cancer cells.
  • To elucidate the molecular mechanisms by which MED28 influences cancer cell motility.

Main Methods:

  • MED28 knockdown and overexpression in human breast cancer cells.
  • Assessment of cellular migration and invasion assays.
  • Analysis of matrix metalloproteinase-2 (MMP2) and mitogen-activated protein kinase kinase 1 (MAP2K1; MEK1) expression levels.
  • Functional studies using dominant-negative MEK1 constructs, MEK1-specific siRNA, MEK1 inhibitors, and recombinant MMP2.

Main Results:

  • MED28 suppression inhibited cell migration and invasion, reducing MMP2 and MEK1 expression.
  • MED28 overexpression enhanced cell migration and upregulated MMP2 and MEK1.
  • MEK1 inhibition blocked MED28-induced MMP2 activation, migration, and invasion.
  • Ectopic MEK1 expression rescued MED28 knockdown effects, and exogenous MMP2 restored invasion.

Conclusions:

  • MED28 regulates human breast cancer cell migration and invasion.
  • The MEK1/MAPK pathway is essential for MED28-mediated cellular motility.
  • MED28 plays a significant role in promoting breast cancer progression via MEK1 and MMP2.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Cell Migration01:09

Cell Migration

Cell migration, the process by which cells move from one location to another, is essential for the proper development and viability of organisms throughout their life. When cells are not able to migrate properly to their ordained locations, various disorders may occur. For example, disruption in cell migration causes chronic inflammatory diseases such as arthritis.
Cell Migration01:19

Cell Migration

Cell migration is a process by which the cells move from one location to another, playing an essential role in embryological development, repair and regeneration, immune response, and metastasis. Cells migrate in response to chemical or mechanical signals generated by specific organs or tissues. The overall mechanism includes three steps - polarization, protrusion, and release. Polarization involves the formation of a distinct cell front and rear, which determines the direction of movement.
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...